The phosphoinositide second messenger system in human OPCA and the mouse model.
Desaiah
D
D
Department of Neurology, University of Mississippi Medical Center, Jackson 39216.
Subramony
S H
SH
Vig
P J
PJ
Currier
R D
RD
D000818:Animals; D001921:Brain / Q000473:pathology; D002118:Calcium / Q000378:metabolism; D015220:Calcium Channels; D002540:Cerebral Cortex / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007293:Inosine Triphosphate / Q000378:metabolism; D053496:Inositol 1,4,5-Trisphosphate Receptors; D051379:Mice; D008818:Mice, Neurologic Mutants; D008861:Microsomes / Q000378:metabolism; D009849:Olivopontocerebellar Atrophies / Q000473:pathology*; D010716:Phosphatidylinositols / Q000502:physiology*; D011493:Protein Kinase C / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000187:drug effects / Q000378:metabolism; D018160:Receptors, Cytoplasmic and Nuclear; D015290:Second Messenger Systems / Q000502:physiology*
D015220:Calcium Channels; C506926:ITPR1 protein, human; D053496:Inositol 1,4,5-Trisphosphate Receptors; D010716:Phosphatidylinositols; D011956:Receptors, Cell Surface; D018160:Receptors, Cytoplasmic and Nuclear; D007293:Inosine Triphosphate; D011493:Protein Kinase C; D002118:Calcium